Organon and QC LGU Empower Women to ‘Take Control’ on World Contraception Day

In a vibrant celebration of World Contraception Day, Organon Philippines and the Quezon City government reaffirmed their shared commitment to empowering Filipino women through informed reproductive health choices. The “Take Control: Buhay Mo, Iplano Mo” initiative gathered hundreds of women for a day centered on agency, awareness, and supportive community action.

Empowerment Through Choice

At the heart of the celebration was a powerful message: women deserve the knowledge and the freedom to decide what’s right for their bodies and their futures. Organon Asia & the Pacific Medical Director Dr. Christina P. Crisologo emphasized that reproductive empowerment begins with access: to accurate information, to a range of family planning methods, and to supportive health systems.

“Family planning is about choice, control, and confidence,” she said. “When women are equipped with the right information and healthcare, they can make decisions that open doors to healthier, more secure futures for themselves and their families.”

Energy and empowerment take center stage as participants join the EmpowHER Zumba session, turning movement into a celebration of confidence, choice, and reproductive health. The activity highlights that when women feel supported and informed, they gain the power to plan their lives with freedom and control.

Quezon City as a Model for Reproductive Health

The partnership with the local government highlighted Quezon City’s strong track record as one of the country’s leading LGUs in reproductive health. Representing Mayor Joy Belmonte, Dr. Elenita R. Plata, Quezon City Health Department’s Medical Coordinator for Maternal, Newborn and Child Health & Nutrition, reaffirmed the city’s longstanding belief that equitable healthcare is foundational to community well-being.

She noted QC’s consistent investment in reproductive health programs, from accessible health centers and trained providers to aggressive information campaigns and family planning services that are available to all. These efforts have translated into real impact, including the reduction of maternal mortality cases from 135 in 2022 to 117 in 2024.

“Family planning is a public health priority in Quezon City. By preventing unplanned pregnancies, we prevent avoidable maternal deaths,” she said. “Awareness leads to access and access saves lives.”

Educating Women on Modern Family Planning Options

A central part of the program was an expert-led discussion by Dr. Khristine Vine Dubhe Jadjuli, anOB-Gynecologist, who walked participants through various modern contraceptive options. She stressed that reproductive health should never be approached with a one-size-fits-all mindset.

“Every woman’s body and life situation is unique,” she explained. “Proper consultation with a healthcare professional is essential to choosing the method that works best for you.”

This educational component reinforced the day’s core mission, empowering women to make informed decisions grounded in science, personal preference, and accessible support.

Turning Personal Commitments Into Global Impact

The event culminated in a “Commitment Exercise,” where attendees pledged to advocate for informed reproductive health choices in their own communities. For every pledge, Organon donates US$1 to the United Nations Population Fund (UNFPA), extending the impact from Quezon City to vulnerable women across the Asia-Pacific region.

By day’s end, one message stood firm: reproductive health is not just a policy or a medical service, it is a pathway to women’s empowerment. Through partnerships like this and with LGUs like Quezon City leading by example, more women are gaining the knowledge, confidence, and support to shape the lives they envision. ###

About Organon

Organon is a global healthcare company with a focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialise their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,300 employees with headquarters located in Jersey City, New Jersey.

Copyright © (2025) Organon group of companies.  All rights reserved.